Log in to your Inderes Free account to see all free content on this page.
Implantica
47.45 SEK
-0.11 %
Less than 1K followers
IMP A SDB
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.11 %
-12.13 %
-34.37 %
+19.22 %
+37.94 %
+26.03 %
+18.92 %
-62.04 %
-50.86 %
Implantica operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes implantable medical instruments, which are also used for the treatment of diseases affecting the esophagus. In addition to the main business, related ancillary services are offered, particularly focused on eHealth. The business is operated globally with the largest presence in North America and Europe.
Read moreMarket cap
56.14B SEK
Turnover
501.38K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25.2.
2026
Annual report '25
All
Webcasts
Press releases
ShowingAll content types
Implantica: RefluxStop® "Best in Class" at Japan Foregut Conference as 5-Year Data and Extensive Safety Cohort is Presented to 120 Leading Surgeons
Implantica: RefluxStop® takes center stage at 2025 European Foregut Society meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
